Literature DB >> 17854131

From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?

Giovanni Tarantino.   

Abstract

There is a general consensus in re-interpreting the so-called liver function tests in the light of novel discoveries. At the same time, recent evidence favours the use of different laboratory data to assess liver damage, fibrosis or regenerative process, but this point is not always shared. Actually, balancing the need for diagnosis, prognostic evaluation and therapy response of liver disease with a good cost/benefit ratio is very difficult. New tests are probably not needed but the aim should be for better utilization of existing tests to contain the increasing cost of health care.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854131      PMCID: PMC4434613          DOI: 10.3748/wjg.v13.i37.4917

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities.

Authors:  F DE RITIS; M COLTORTI; G GIUSTI
Journal:  Clin Chim Acta       Date:  1957-02       Impact factor: 3.786

2.  Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.

Authors:  E P A Lopes; E C Gouveia; A C C Albuquerque; L H B C Sette; L A Mello; R C Moreira; M R C D Coelho
Journal:  J Clin Virol       Date:  2005-11-11       Impact factor: 3.168

3.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.

Authors:  Roger K Schindhelm; Jacqueline M Dekker; Giel Nijpels; Lex M Bouter; Coen D A Stehouwer; Robert J Heine; Michaela Diamant
Journal:  Atherosclerosis       Date:  2006-05-08       Impact factor: 5.162

4.  Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern.

Authors:  Eran Elinav; Iddo Z Ben-Dov; Elizabeth Ackerman; Alexander Kiderman; Frida Glikberg; Yami Shapira; Zvi Ackerman
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

5.  Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.

Authors:  Hyeon-Chang Kim; Sung-Hee Choi; Hae-Won Shin; Jae-Youn Cheong; Kwan-Woo Lee; Hyun-Chul Lee; Kap-Bum Huh; Dae-Jung Kim
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

6.  Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.

Authors:  G Tarantino; P Conca; A Coppola; R Vecchione; G Di Minno
Journal:  Eur J Clin Invest       Date:  2007-01       Impact factor: 4.686

7.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

Authors:  P André; B Balkau; C Born; M A Charles; E Eschwège
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

8.  MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.

Authors:  George V Papatheodoridis; Evangelos Cholongitas; Eleni Dimitriadou; Giota Touloumi; Vassilios Sevastianos; Athanasios J Archimandritis
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

9.  Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Authors:  Douglas S Lee; Jane C Evans; Sander J Robins; Peter W Wilson; Irene Albano; Caroline S Fox; Thomas J Wang; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-09       Impact factor: 8.311

10.  Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.

Authors:  Ewa Janczewska-Kazek; Bogdan Marek; Dariusz Kajdaniuk; Halina Borgiel-Marek
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.